BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28084860)

  • 21. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy.
    May M; Brookman-May S; Burger M; Gilfrich C; Fritsche HM; Rink M; Chun F; Fisch M; Roghmann F; Noldus J; Mayr R; Pycha A; Novotny V; Wirth M; Vallo S; Haferkamp A; Roigas J; Brisuda A; Stredele R; Volkmer B; Dechet C; Schnabel M; Denzinger S; Stief CG; Bastian PJ; Aziz A
    Ann Surg Oncol; 2014 Nov; 21(12):4034-40. PubMed ID: 24895114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladder.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Holmäng S; Babjuk M; Fajkovic H; Seitz C; Klatte T; Pycha A; Bachmann A; Scherr DS; Shariat SF
    Eur Urol; 2014 Jan; 65(1):201-9. PubMed ID: 23998688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.
    Supit W; Mochtar CA; Sugiono M; Umbas R
    Asian Pac J Cancer Prev; 2011; 12(2):549-53. PubMed ID: 21545228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
    Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
    Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological staging of muscle invasive bladder cancer. Is substaging of pT2 tumors really necessary?
    Tokgoz H; Turkolmez K; Resorlu B; Kose K; Tulunay O; Beduk Y
    Int Braz J Urol; 2007; 33(6):777-83; discussion 783-4. PubMed ID: 18199345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.
    Schned AR; Andrew AS; Marsit CJ; Zens MS; Kelsey KT; Karagas MR
    J Urol; 2007 Oct; 178(4 Pt 1):1196-200; discussion 1200. PubMed ID: 17698105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?
    Scosyrev E; Yao J; Messing E
    Urology; 2009 Apr; 73(4):822-7. PubMed ID: 19193403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
    Lucca I; Rouprêt M; Kluth L; Rink M; Tilki D; Fajkovic H; Kassouf W; Hofbauer SL; de Martino M; Karakiewicz PI; Briganti A; Trinh QD; Seitz C; Fritsche HM; Burger M; Lotan Y; Kramer G; Shariat SF; Klatte T
    BJU Int; 2015 May; 115(5):722-7. PubMed ID: 24905084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder.
    Xylinas E; Kluth LA; Lotan Y; Daneshmand S; Rieken M; Karakiewicz PI; Shariat SF
    Urol Oncol; 2014 Apr; 32(3):230-42. PubMed ID: 24332648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.
    Mitra AP; Skinner EC; Schuckman AK; Quinn DI; Dorff TB; Daneshmand S
    Urol Oncol; 2014 Jan; 32(1):52.e1-9. PubMed ID: 24239476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Editorial Comment to Cancer death from non-muscle invasive bladder cancer: Report of the Japanese Urological Association of data from the 1999-2001 registry in Japan.
    Koga F
    Int J Urol; 2010 Nov; 17(11):913. PubMed ID: 20969638
    [No Abstract]   [Full Text] [Related]  

  • 38. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
    Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
    Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
    Vaidya S; Lakhey M; K C S; Hirachand S
    JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.